Hand ultrasound for the diagnosis of scleroderma: a scoring strategy including US items and items from the EULAR/ACR classification.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 28 04 2020
accepted: 06 07 2020
entrez: 1 9 2020
pubmed: 1 9 2020
medline: 18 9 2020
Statut: ppublish

Résumé

To evaluate the diagnostic value of hand ultrasound (US) in systemic sclerosis (SSc) and to explore its relevance within a combined diagnostic approach. 224 patients with suspected SSc were consecutively included. They all had US evaluation assessing the presence of fibrotic tenosynovitis (fibrotic TS) and ulnar artery occlusion (UAO). The final diagnosis of SSc was based on the clinical evaluation of a board of experts independently of any pre-established classification criteria. 166 patients were finally diagnosed as SSc according to the experts as reference standard. 62 SSc and 8 non-SSc patients had UAO (uni or bilateral) (p=0.001). 23 SSc patients and 1 non-SSc patient had US fibrotic TS (p=0.007). A US SSc-pattern (presence of UAO and/or fibrotic TS) was reported in 73 SSc patients and 9 non-SSc patients (p<0.001). UAO had an area under ROC curve (AUC) for the diagnosis of SSc of 0.618 (95%CI 0.539- 0.697); with Se=0.373 (0.304-0.449) and Sp=0.862 (0.751-0.928). Fibrotic TS had an AUC of 0.561 (0.480-0.643); with Se=0.139 (0.094-0.199) and Sp=0.983 (0.909-0.997). The US-SSc pattern had a AUC of 0.641 (0.563- 0.695), with Se=0.440 (0.367-0.516) and Sp=0.845 (0.731-0.916). A scoring system including these US parameters and items from ACR/EULAR classification criteria had an AUC of 0.979 (0.962-0.996)) and allows the substitution of capillaroscopy by US parameters with similar performances. The use of hand US parameters may help to refine the diagnostic strategy of SSc and their inclusion in a combined diagnostic approach could be discussed.

Identifiants

pubmed: 32865172
pii: 15728

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Auteurs

Marine de Saint Riquier (M)

Department of Rheumatology, CHU Rennes, Université de Rennes, France.

Alice Ballerie (A)

Department of Internal Medicine and Clinical Immunology, CHU Rennes, Université de Rennes; and Université de Rennes, CHU Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.

François Robin (F)

Department of Rheumatology, CHU Rennes, Université de Rennes; and Inserm U 1241, Université de Rennes, France.

Nicolas Belhomme (N)

Department of Internal Medicine and Clinical Immunology, CHU Rennes, Université de Rennes, France.

Claire Cazalets (C)

Department of Internal Medicine and Clinical Immunology, CHU Rennes, Université de Rennes, France.

Catherine Droitcourt (C)

Université de Rennes; CHU Rennes, Department of Dermatology; INSERM, CIC 1414, Rennes; REPERES Pharmacoepidemiology and access to Health Care, University Rennes 1 and French School of Public Health, UPRES EA 7449, Rennes, France.

Aleth Perdriger (A)

Department of Rheumatology, CHU Rennes, Université de Rennes, France.

Cécile Marie Yelnik (CM)

Université de Lille, U995, Lille Inflammation Research International Centre; and CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, France.

Eric Hachulla (E)

Université de Lille, U995, Lille Inflammation Research International Centre; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille; Inserm, Lille; and Centre National de Référence Maladies Systémiques et Auto-Immunes Rares du Nord et Nord-Ouest de France, Lille, France.

Vincent Sobanski (V)

Université de Lille, U995, Lille Inflammation Research International Centre; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille; Inserm, Lille; and Centre National de Référence Maladies Systémiques et Auto-Immunes Rares du Nord et Nord-Ouest de France, Lille, France.

Patrick Jégo (P)

Department of Internal Medicine and Clinical Immunology, CHU Rennes, Université de Rennes; and Université de Rennes, CHU Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.

Guillaume Coiffier (G)

Department of Rheumatology, CHU Rennes, Université de Rennes; and Inserm U 1241, Université de Rennes, France.

Alain Lescoat (A)

Department of Internal Medicine and Clinical Immunology, CHU Rennes, Université de Rennes; and Université de Rennes, CHU Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France. alain.lescoat@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH